Drug Information

Drug General Information
Drug ID
D0P1FO
Former ID
DAP000207
Drug Name
Marinol
Synonyms
Compassia; Deltanyne; Dronabinol; Dronabinolum; Ganja; Hashish; Marincap; MaxEPA; Namisol; Omegaven; Promega; Relivar; Sonergx; TETRAHYDROCANNABINOL; THC; Tetranabinex; Cannabis resin; Drona binol; Dronabinolum [Latin]; Abbott 40566; QCD 84924; SP 104; Tetrahydrocannabinol delta9; CAT-310; DELTA1-THC; DELTA1-Tetrahydrocannabinol;DELTA9-THC; DRG-0138; Delta-THC; Delta1-THC; Delta1-Tetrahydrocannabinol; Delta9-THC; Delta9-Tetrahydrocannabinol; Delta9-Tetrahydrocannabinol solution; Dronabinol [USAN:INN]; Marinol (TN); Pro-Mega;QCD-84924; Trans-tetrahydrocannabinol; DELTA9-trans-Tetrahydrocannabinol; Delta(1)-THC; Delta(1)-Tetrahydrocannabinol; Delta(9)-THC; Delta(9)-Tetrahydrocannabinol; Delta(9)-Tetrahydrocannibinol; Delta(sup 1)-Tetrahydrocannabinol; Delta(sup 1)-Thc; Delta(sup 9)-Tetrahydrocannabinol; Delta(sup 9)-Thc; Delta(sup9)-THC; Delta-9-THC; Delta-9-tetrahydrocannabinol; Delta1-Tetrahydrocannabinol (VAN); Delta9-Tetrahydrocannabinol (VAN); Delta9-trans-Tetrahydrocannabinol; Dronabinol (USP/INN); Omega-3-Fatty acid; THC-delta-9; Trans-delta9-Tetrahydrocannabinol; Cannabinol, tetrahydro-(6CI); Fish oils, n-3 fatty acid-high; Fish oils, omega-3 fatty acid-high; L-delta(sup 1)-tetrahydrocannabinol; L-delta1-trans-Tetrahydrocannabinol; L-trans-delta9-Tetrahydrocannabinol; Trans-delta-9-Tetrahydrocannabinol; Cannabinol, Delta1-tetrahydro-(7CI); Fats and Glyceridic oils, fish, n-3 fatty acid-high; L-.delta.1-Tetrahydrocannabinol; Trans-.DELTA.9-Tetrahydrocannabinol; L-.delta.1-trans-Tetrahydrocannabinol;L-trans-.delta.9-Tetrahydrocannabinol; Tetrahydrocannabinols (-)-delta1-3,4-trans-form; (-)-.DELTA.1-Tetrahydrocannabinol; (-)-.DELTA.9-THC; (-)-.DELTA.9-Tetrahydrocannabinol; (-)-.DELTA.9-trans-Tetrahydrocannabinol; (-)-.delta.(sup9)-trans-Tetrahydrocannabinol; (-)-3,4-trans-Delta1-Tetrahydrocannabinol; (-)-delta(sup 1)-3,4-trans-Tetrahydrocannabinol; (-)-delta1-Tetrahydrocannabinol; (-)-delta9-(trans)-Tetrahydrocannabinol; (-)-delta9-Tetrahydrocannabinol; (-)-delta9-trans-Tetrahydrocannabinol; (-)-trans-.DELTA.9-Tetrahydrocannabinol; (-)-trans-Delta1-Tetrahydrocannabinol; (-)-trans-Delta9-THC; (-)-trans-delta9-Tetrahydrocannabinol; (L)-.delta.1-Tetrahydrocannabinol; (l)-delta(sup 1)-Tetrahydrocannabinol; (l)-delta1-Tetrahydrocannabinol; 1-trans-.delta.(sup9)-tetrahydrocannabinol; 1-trans-D9-Tetrahydrocannabinol; 1-trans-delta(sup 9)-Tetrahydrocannabinol; 1-trans-delta(sup9)-tetrahydrocannabinol; 1-trans-delta-9-Tetrahydrocannabinol; 1-trans-delta9-Tetrahydrocannabinol; 14C-.DELTA.1-Tetrahydrocannabinol; 6H-Dibenzo; 9-delta-Tetrahydrocannabinol; 9-ene-Tetrahydrocannabinol; 9-tetrahydrocannabinol
Drug Type
Small molecular drug
Indication Anorexia [ICD9: 307.1; ICD10:F50.0-F50.1] Approved [538510]
Therapeutic Class
Analgesics
Company
Unimed Pharmaceuticals
Structure
Download
2D MOL

3D MOL
Formula
C21H30O2
Canonical SMILES
CCCCCC1=CC2=C(C3C=C(CCC3C(O2)(C)C)C)C(=C1)O
InChI
1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1
InChIKey
CYQFCXCEBYINGO-IAGOWNOFSA-N
CAS Number
CAS 1972-08-3
PubChem Compound ID
16078
PubChem Substance ID
9186, 423124, 590069, 841255, 7847372, 7980767, 8162055, 12013925, 14776764, 14899056, 24900035, 24900224, 29283967, 46508472, 47289005, 48414516, 48422188, 49681167, 49855137, 53790103, 56311071, 56365468, 57288574, 57329243, 57654672, 68530527, 78512325, 93166585, 103167825, 103920666, 104338871, 113635228, 117426979, 127309746, 127309747, 127309748, 127309749, 127309750, 127309751, 127309752, 127309753, 127340561, 127340562, 127340563, 127340564, 127344438, 127696830, 134337522, 134339937, 134982169
SuperDrug ATC ID
A04AD10
SuperDrug CAS ID
cas=001972083
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Agonist [537087]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 538510FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 018651.
Ref 537087Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br J Pharmacol. 2009 Feb;156(3):397-411.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.